结核病与肺部健康杂志 ›› 2017, Vol. 6 ›› Issue (3): 279-293.doi: 10.3969/j.issn.2095-3755.2017.03.000

• 综述 • 上一篇    下一篇

瞬时受体电位通道蛋白C与肺动脉高压

徐磊,付秀华   

  1. 010050 内蒙古医科大学附属医院呼吸与危重症医学科
  • 收稿日期:2017-03-27 出版日期:2017-09-30 发布日期:2017-09-30
  • 作者简介:付秀华

Transient receptor potential channels proteins and the pathogenesis of pulmonary hypertension

XU Lei, FU Xiu-hua   

  1. Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2017-03-27 Online:2017-09-30 Published:2017-09-30

摘要: 肺动脉高压致死致残率高,是一种严重威胁人类健康疾病,对其发病机制的研究非常重要。在肺动脉高压发病机制中,肺血管平滑肌细胞内Ca2+浓度的增加是核心因素,Ca2+浓度的增加会引起细胞的增殖进而引起肺动脉高压。细胞内Ca2+浓度主要受细胞膜Ca2+通道的调节,瞬时受体电位通道蛋白C是Ca2+通道蛋白的主要成分。瞬时受体电位通道蛋白C1、4、6参与了肺动脉高压的发病,笔者对其具体机制进行了综述。

Abstract: Pulmonary hypertension is one of the diseases that seriously threaten to human health with significant mortality and disability rate. It is vital to explore the mechanism of pathogenesis of pulmonary hypertension for its prevention and treatment. The increase in Ca2+ concentration of pulmonary artery smooth muscles cells enhances cell proliferation and consequent causes occurrence of pulmonary hypertension, which plays a core role in the pathogenesis of pulmonary hypertension. The Ca2+ concentration of cells is regulated by calcium channels on cell membrane. The transient receptor potential channel C (TRPC) is the main component of calcium channels, and TRPC1/4/6 are involved in pathogenesis of pulmonary hypertension. In the present article, we reviewed the pathogenesis of pulmonary hypertension in detail.